Invest now

Poly Medicure Profit & Loss Annual

BSE: 531768 | NSE: POLYMED | ISIN: INE205C01021 | Sector: Medical Equipment & Supplies
1,626.40 +9.00 (0.56%)Updated : 06 Oct 2026
Research on
Fiscal Period2026202520242023
Period End DateMar 26Mar 25Mar 24Mar 23
Total Operating Expense 1,553.141,297.351,078.56906.69
Other Net 13.718.756.0015.44
Diluted Weighted Average Shares 10.149.929.609.60
Gain( Loss)on Saleof Assets -0.220.120.620.10
Depreciation/ Amortization 115.5283.1863.9157.12
Operating Income 322.12372.48297.23208.54
Net Income 322.14338.56258.26179.28
Income Availableto Com Excl Extra Ord 322.14338.56258.26179.28
Other Operating Expenses Total 16.6612.1711.568.16
Net Income Before Taxes 427.47452.52344.27237.49
Minority Interest 1.41---
Interest Exp( Inc) Net- Operating Total 0.000.000.020.04
Net Income After Taxes 320.73338.56258.26179.28
Income Availableto Com Incl Extra Ord 322.14338.56258.26179.28
Costof Revenue Total 816.40706.95648.61547.91
Gross Profit 1,058.86962.89727.19567.32
Interest Inc( Exp) Net- Non- Op Total 91.8671.1640.4113.41
Unusual Expense( Income) 4.91-2.12-2.61-
Diluted Net Income 322.14338.56258.26179.28
DPS- Common Stock Primary Issue 3.503.503.003.00
Provisionfor Income Taxes 106.74113.9686.0158.21
period Type ----
Net Income Before Extra Items 322.14338.56258.26179.28
Total Revenue 1,875.261,669.831,375.801,115.23
period Length 12.0012.0012.0012.00
Revenue 1,875.261,669.831,375.801,115.23
Selling/ General/ Admin Expenses Total 569.79472.60338.12275.66
Diluted Normalized EPS 32.1333.9426.6418.66
Research Development 29.8824.5718.9617.80
Diluted EPS Excluding Extra Ord Items 31.7534.1126.9018.67
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,035.00+40.00(4.02%)
1,246.00+17.00(1.38%)
11,400.00-549.00 (-4.59%)